Mutual Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Buy
544
+39
+8% +$21.9K 0.01% 1190
2026
Q1
$284K Buy
505
+29
+6% +$18.6K 0.01% 1147
2025
Q4
$322K Sell
476
-1
-0.2% -$681 0.01% 1051
2025
Q3
$305K Buy
477
+46
+11% +$27.9K 0.01% 1046
2025
Q2
$244K Buy
+431
New +$206K 0.01% 1057
2024
Q3
Sell
-806
Closed -$381K 1136
2024
Q2
$381K Buy
806
+338
+72% +$170K 0.01% 804
2024
Q1
$253K Hold
468
0.01% 941
2023
Q4
$260K Buy
+468
New +$220K 0.01% 873
2023
Q2
Sell
-423
Closed -$212K 1031
2023
Q1
$212K Buy
+423
New +$202K 0.01% 911
2021
Q4
Sell
-381
Closed -$237K 907
2021
Q3
$237K Sell
381
-215
-36% -$144K 0.01% 778
2021
Q2
$376K Buy
596
+50
+9% +$27.6K 0.02% 619
2021
Q1
$267K Buy
+546
New +$274K 0.02% 654

Other funds holding IDXX

Mutual Advisors's IDXX Position: Q2 2026 in Review

Mutual Advisors increased its Idexx Laboratories (IDXX) stake by 7.7% in Q2 2026, buying an estimated $21.9K and bringing the position to 544 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #1190.

Mutual Advisors first reported a position in IDXX in Q1 2021 and has held it in 12 quarters since. The position peaked at $381K in Q2 2024. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Mutual Advisors held 544 shares of Idexx Laboratories worth $286K as of Q2 2026.
  • Mutual Advisors bought 39 Idexx Laboratories shares in Q2 2026, an estimated $21.9K.
  • Idexx Laboratories made up 0.01% of Mutual Advisors's portfolio in Q2 2026, its #1190 holding.
  • Mutual Advisors first reported a position in Idexx Laboratories in Q1 2021 and has held it in 12 quarters since.
  • Mutual Advisors's Idexx Laboratories position peaked at $381K in Q2 2024.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Mutual Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.